NasdaqGM - Delayed Quote USD

XOMA Corporation (XOMAO)

Compare
25.23 +0.05 (+0.20%)
At close: June 20 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
5,811.00
4,758.00
6,027.00
38,160.00
29,385.00
--
Operating Expense
28,665.00
26,646.00
23,441.00
20,631.00
16,969.00
--
Operating Income
-22,854.00
-21,888.00
-17,414.00
17,529.00
12,416.00
--
Net Non Operating Interest Income Expense
-4,120.00
-569.00
--
-461.00
-1,844.00
--
Other Income Expense
-12,639.00
-18,374.00
295.00
-1,179.00
1,225.00
--
Pretax Income
-39,613.00
-40,831.00
-17,119.00
15,889.00
11,797.00
--
Tax Provision
--
--
-15.00
91.00
-1,501.00
--
Net Income Common Stockholders
-45,085.00
-46,303.00
-22,576.00
7,787.00
8,793.00
--
Average Dilution Earnings
--
--
--
181.00
217.00
--
Diluted NI Available to Com Stockholders
-45,085.00
-46,303.00
-22,576.00
7,968.00
9,010.00
--
Total Operating Income as Reported
-38,682.00
-41,848.00
-17,414.00
17,529.00
12,416.00
--
Total Expenses
28,665.00
26,646.00
23,441.00
20,631.00
16,969.00
--
Net Income from Continuing & Discontinued Operation
-39,613.00
-40,831.00
-17,104.00
15,798.00
13,298.00
--
Normalized Income
-26,974.00
-22,457.00
-17,358.78
16,970.16
12,443.17
--
Interest Expense
4,120.00
569.00
--
461.00
1,844.00
--
Net Interest Income
-4,120.00
-569.00
--
-461.00
-1,844.00
--
EBIT
-35,493.00
-40,262.00
-17,119.00
16,350.00
13,641.00
--
EBITDA
-34,817.00
-39,362.00
-17,015.00
16,357.00
13,663.00
--
Reconciled Depreciation
676.00
900.00
104.00
7.00
22.00
--
Net Income from Continuing Operation Net Minority Interest
-39,613.00
-40,831.00
-17,104.00
15,798.00
13,298.00
--
Total Unusual Items Excluding Goodwill
-12,639.00
-18,374.00
255.00
-1,184.00
1,171.00
--
Total Unusual Items
-12,639.00
-18,374.00
255.00
-1,184.00
1,171.00
--
Normalized EBITDA
-22,178.00
-20,988.00
-17,270.00
17,541.00
12,492.00
--
Tax Rate for Calcs
--
--
0.00
0.00
0.00
--
Tax Effect of Unusual Items
--
--
0.22
-11.84
316.17
--
12/31/2019 - 4/12/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CLVLY Clinuvel Pharmaceuticals Limited
10.11
0.00%
 
CWBR CohBar, Inc.
0.7601
0.00%
 
CUV.AX Clinuvel Pharmaceuticals Limited
15.10
+0.94%
 
NERV Minerva Neurosciences, Inc.
3.4400
-1.99%
 
MOLN Molecular Partners AG
11.01
+38.49%
 
BHVN Biohaven Ltd.
33.44
+2.04%
 
FBIO Fortress Biotech, Inc.
1.7100
-4.47%
 
NNVC NanoViricides, Inc.
2.0300
+23.78%
 
LGVN Longeveron Inc.
2.4500
+10.36%